The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It has a policy of investing at least 25% of its assets in investments in the medical research and health care industry.
Period | ETHSX Return | Category Return Low | Category Return High | Rank in Category (%) | Quintile |
---|---|---|---|---|---|
YTD | 1.1% | -14.9% | 22.3% | 66.07% | 4 |
1 Yr | 5.2% | -14.8% | 35.3% | 80.18% | 4 |
3 Yr | -0.9% * | -7.5% | 17.2% | 82.41% | 5 |
5 Yr | 11.2% * | 8.0% | 21.3% | 83.18% | 5 |
10 Yr | 11.5% * | 6.1% | 18.5% | 66.02% | 4 |
* Annualized
Period | ETHSX Return | Category Return Low | Category Return High | Rank in Category (%) | Quintile |
---|---|---|---|---|---|
2017 | 13.1% | -19.5% | 43.9% | 60.00% | 3 |
2016 | -24.6% | -29.8% | 14.5% | 93.64% | 5 |
2015 | -1.4% | -20.4% | 33.7% | 41.82% | 3 |
2014 | 9.0% | -5.8% | 48.1% | 70.00% | 4 |
2013 | 27.6% | -3.1% | 65.2% | 79.82% | 4 |
Period | ETHSX Return | Category Return Low | Category Return High | Rank in Category (%) | Quintile |
---|---|---|---|---|---|
YTD | 1.1% | -14.9% | 22.3% | 66.67% | 4 |
1 Yr | -0.9% | -18.3% | 35.3% | 92.73% | 5 |
3 Yr | -2.9% * | -14.2% | 16.4% | 93.52% | 5 |
5 Yr | 9.9% * | 7.4% | 21.3% | 89.72% | 5 |
10 Yr | 10.8% * | 6.1% | 18.5% | 73.79% | 4 |
* Annualized
Period | ETHSX Return | Category Return Low | Category Return High | Rank in Category (%) | Quintile |
---|---|---|---|---|---|
2017 | 13.1% | -19.5% | 43.9% | 60.55% | 3 |
2016 | -24.6% | -25.1% | 39.1% | 97.25% | 5 |
2015 | 9.0% | -16.6% | 100.0% | 33.94% | 2 |
2014 | 37.6% | -5.8% | 79.8% | 35.78% | 2 |
2013 | 92.3% | 0.0% | 398.7% | 28.70% | 2 |
ETHSX | Category Low | Category High | ETHSX % Rank | Quintile | |
---|---|---|---|---|---|
Net Assets | 997 M | 16.9 M | 46 B | 19.64% | 3 |
Number of Holdings | 57 | 32 | 363 | 23.21% | 4 |
Net Assets in Top 10 | 423 M | 10.6 M | 19.1 B | 21.43% | 3 |
Weighting of Top 10 | 41.2% | 21.5% | 74.1% | 16.07% | 2 |
Weighting | Category Low | Category High | ETHSX % Rank | Quintile | |
---|---|---|---|---|---|
Stocks | 99.40% | 92.18% | 101.98% | 5.36% | 1 |
Other | 0.59% | -3.44% | 4.71% | 7.14% | 2 |
Cash | 0.01% | 0.00% | 7.67% | 34.82% | 5 |
Preferred Stocks | 0.00% | 0.00% | 2.19% | 11.61% | 5 |
Convertible Bonds | 0.00% | 0.00% | 0.39% | 3.57% | 5 |
Bonds | 0.00% | 0.00% | 4.69% | 3.57% | 5 |
Weighting | Category Low | Category High | ETHSX % Rank | Quintile | |
---|---|---|---|---|---|
Healthcare | 97.01% | 9.40% | 99.78% | 12.50% | 2 |
Consumer Cyclical | 1.33% | 0.00% | 6.38% | 1.79% | 1 |
Technology | 1.06% | 0.00% | 69.90% | 16.96% | 3 |
Utilities | 0.00% | 0.00% | 0.92% | 1.79% | 5 |
Real Estate | 0.00% | 0.00% | 1.61% | 2.68% | 5 |
Industrials | 0.00% | 0.00% | 8.30% | 9.82% | 5 |
Financial Services | 0.00% | 0.00% | 2.20% | 5.36% | 5 |
Energy | 0.00% | 0.00% | 0.10% | 1.79% | 5 |
Communication Services | 0.00% | 0.00% | 0.00% | 0.89% | 5 |
Consumer Defense | 0.00% | 0.00% | 1.31% | 12.50% | 5 |
Basic Materials | 0.00% | 0.00% | 0.32% | 2.68% | 5 |
Weighting | Category Low | Category High | ETHSX % Rank | Quintile | |
---|---|---|---|---|---|
US | 82.40% | 62.35% | 99.47% | 27.68% | 4 |
Non US | 17.00% | 0.00% | 36.67% | 7.14% | 2 |
ETHSX Fees (% of AUM) | Category Low | Category High | Rank in Category (%) | Quintile | |
---|---|---|---|---|---|
Expense Ratio | 1.35% | 0.10% | 4.31% | 34.82% | 3 |
Management Fee | 0.91% | 0.09% | 1.25% | 5.36% | 4 |
12b-1 Fee | 0.25% | 0.00% | 1.00% | 8.86% | 2 |
Administrative Fee | 0.15% | 0.01% | 0.40% | 6.15% | 4 |
ETHSX Fees (% of AUM) | Category Low | Category High | ETHSX Rank | Quintile | |
---|---|---|---|---|---|
Front Load | 5.75% | 2.50% | 5.75% | 3.85% | 5 |
Deferred Load | N/A | 1.00% | 5.00% | N/A | N/A |
ETHSX Fees (% of AUM) | Category Low | Category High | ETHSX Rank | Quintile | |
---|---|---|---|---|---|
Max Redemption Fee | N/A | 0.75% | 2.00% | N/A | N/A |
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
ETHSX Fees (% of AUM) | Category Low | Category High | ETHSX Rank | Quintile | |
---|---|---|---|---|---|
Turnover | 36.00% | 0.00% | 699.00% | 16.96% | 3 |
ETHSX | Category Low | Category High | ETHSX % Rank | Quintile | |
---|---|---|---|---|---|
Dividend Yield | N/A | 0.01% | 6.49% | N/A | N/A |
ETHSX | Category Low | Category High | Category Mode | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Quarterly | Annually |
Date | Amount |
---|---|
Apr 30, 2010 | $0.029 |
Jan 15, 2004 | $0.033 |
Oct 15, 2002 | $0.032 |
Jun 17, 2002 | $0.036 |
Sep 29, 2000 | $0.154 |
Dec 14, 1999 | $0.031 |
Oct 01, 1999 | $0.127 |
Dec 22, 1998 | $0.075 |
Aug 26, 1997 | $0.033 |
Sep 18, 1996 | $0.068 |
ETHSX | Category Low | Category High | ETHSX % Rank | Quintile | |
---|---|---|---|---|---|
Net Income Ratio | -0.02% | -2.22% | 1.46% | 27.68% | 2 |
ETHSX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Manager
Start Date
Jul 01, 2016Tenure
1.75
Tenure Rank
24.3%
Mr. Kritzer is a Vice President of Eaton Vance. Prior to joining Eaton Vance in 2012, Mr. Kritzer was a director and equity analyst at BlackRock , Inc. covering the healthcare sector since 2006.
Manager
Start Date
Jul 01, 2016Tenure
1.75
Tenure Rank
24.3%
Ms. Pandolfi Prior to joining EVMI as a Vice President in November 2015, Ms. Pandolfi was a Portfolio Manager and Research Analyst with Goldman Sachs Asset Management over her fifteen year tenure
Category Low
0.0
Category High
20.6
Category Average
9.28
Category Mode
3.3